Concourse Financial Group Securities, Inc. Neovasc Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$15.81 - $29.88 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$6.5 - $16.05 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$5.95 - $7.93 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$4.9 - $10.75 $0 - $0
0 New
0 $0

About NEOVASC INC

NVCN Quotes by TradingView
  • Ticker NVCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,743,140
  • Description
  • Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...
More about NVCN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email